29-30 April 2017
Pan-European Consensus Conference on Newborn Screening for Haemoglobinopathies
This 2 day Pan-European Consensus Conference on Newborn Screening for Haemoglobinopathies is aiming to evaluate the current situation of sickle cell disease (SCD) in the national newborn screening programs in Europe and across the globe. The focus will be towards the various screening strategies currently in use, particularly the more recent high throughput / point-of-care testing methods.
Resonance Health’s German Representative, Tilo Stolzke, and our Marketing Director, Melanie Baxter will both be attending this event as delegates to interact with influential leaders in the field and network to promote a further inclusion of SCD screening into the standard of care.
For more information on the conference please click here...